Refractory Kawasaki disease: modified methylprednisolone regimen decreases coronary artery dilatation

Mingming Zhang,Yang Zheng,Xiaohui Li,Shuai Yang,Lin Shi,Aijie Li,Yang Liu
DOI: https://doi.org/10.1038/s41390-021-01576-6
IF: 3.953
2021-05-21
Pediatric Research
Abstract:The use of corticosteroids in Kawasaki disease (KD) is still controversial. The aim of this study was to investigate the safety and effectiveness of modified methylprednisolone (mPSL) regimen as an initial treatment for refractory KD.
pediatrics
What problem does this paper attempt to address?